A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

[1] Altucci L(2001)The promise of retinoids to fight against cancer Nat Rev Cancer 1 181-193

[2] Gronemeyer H(2002)Retinoids and their receptors in cancer development and chemoprevention Crit Rev Oncol Hematol 41 41-55

[3] Sun SY(1997)All-trans-retinoic acid in acute promyelocytic leukemia N Engl J Med 337 1021-1028

[4] Lotan R(2006)Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group J Clin Oncol 24 5703-5710

[5] Tallman MS(1999)A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group Blood 94 1192-1200

[6] Andersen JW(1993)Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group Blood 82 3241-3249

[7] Schiffer CA(2001)Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials Australas J Dermatol 42 91-97

[8] Appelbaum FR(2001)Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 581-593

[9] Feusner JH(2000)Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550) Clin Cancer Res 6 1731-1735

[10] Ogden A(1999)A Phase I study of LGD1069 in adults with advanced cancer Clin Cancer Res 5 1658-1664

[1] Altucci L(2001)The promise of retinoids to fight against cancer Nat Rev Cancer 1 181-193

[2] Gronemeyer H(2002)Retinoids and their receptors in cancer development and chemoprevention Crit Rev Oncol Hematol 41 41-55

[3] Sun SY(1997)All-trans-retinoic acid in acute promyelocytic leukemia N Engl J Med 337 1021-1028

[4] Lotan R(2006)Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group J Clin Oncol 24 5703-5710

[5] Tallman MS(1999)A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group Blood 94 1192-1200

[6] Andersen JW(1993)Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group Blood 82 3241-3249

[7] Schiffer CA(2001)Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials Australas J Dermatol 42 91-97

[8] Appelbaum FR(2001)Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 581-593

[9] Feusner JH(2000)Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550) Clin Cancer Res 6 1731-1735

[10] Ogden A(1999)A Phase I study of LGD1069 in adults with advanced cancer Clin Cancer Res 5 1658-1664